948350-99-0 Usage
Chemical structure
A compound with a naphthyridine backbone, featuring a 2-amine functional group and 5,7-dimethyl-3-phenyl substituents.
Application
Commonly used in pharmaceutical and medicinal chemistry.
Biological activities
Exhibits potent anti-inflammatory and antimicrobial properties.
Drug candidate
Extensively studied for its potential as a drug candidate for various diseases.
Unique structure
Its structure and pharmacological properties make it a valuable tool for drug discovery and development.
Research potential
Diverse range of biological activities make it a promising candidate for further research.
Therapeutic applications
Potential for development into therapeutic applications due to its potent biological activities and unique structure.
Check Digit Verification of cas no
The CAS Registry Mumber 948350-99-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,8,3,5 and 0 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 948350-99:
(8*9)+(7*4)+(6*8)+(5*3)+(4*5)+(3*0)+(2*9)+(1*9)=210
210 % 10 = 0
So 948350-99-0 is a valid CAS Registry Number.
948350-99-0Relevant articles and documents
NOVEL DUAL ACTION RECEPTORS ANTAGONISTS (DARA) AT THE AT1 AND ETA RECEPTORS
-
Page/Page column 273, (2010/11/28)
The present invention relates to new compounds of the formula [Chemical formula should be inserted here. Please see paper copy] wherein R1, R2, R3, and R31 are as specified herein. The invention also relates to a method for preparation thereof, as well as combinations of the new compounds with previously known agents. The invention also relates to the use of the above-mentioned compounds and combinations for the preparation of a medicament for treating hypertension of different kinds, alleviating organ damage of different kinds, treating or preventing diabetic nephropathy, treating endothelin and angiotensin mediated disorders, and treating prostate cancer.
